Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TECLISTAMAB vs TEDIZOLID: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TECLISTAMAB vs TEDIZOLID: Safety Overview

Metric TECLISTAMAB TEDIZOLID
Total FAERS Reports 1,221 769
Deaths Reported 269 68
Death Rate 22.0% 8.8%
Hospitalizations 540 217
Average Patient Age 66.5 yrs 62.3 yrs
% Female Patients 45.7% 46.4%
FDA Approval Date N/A Jun 20, 2014
Manufacturer Janssen Biotech, Inc. Merck Sharp & Dohme LLC
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status N/A Prescription